Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK. Chia S, et al. Among authors: wackers fj. JACC Cardiovasc Interv. 2008 Aug;1(4):415-23. doi: 10.1016/j.jcin.2008.04.010. JACC Cardiovasc Interv. 2008. PMID: 19463339 Free article. Clinical Trial.
Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Cruz-Gonzalez I, Chia S, Raffel OC, Sanchez-Ledesma M, Senatore F, Wackers FJ, Nathan DM, Jang IK. Cruz-Gonzalez I, et al. Among authors: wackers fj. Diabetes Res Clin Pract. 2010 Apr;88(1):97-102. doi: 10.1016/j.diabres.2010.01.001. Epub 2010 Jan 18. Diabetes Res Clin Pract. 2010. PMID: 20083319
A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
Jang IK, Pettigrew V, Picard MH, Kowey PR, Demmel V, Zile MR, Tatsuno J, Wackers FJ, Hibberd M. Jang IK, et al. Among authors: wackers fj. J Thromb Thrombolysis. 2005 Dec;20(3):147-53. doi: 10.1007/s11239-005-3267-4. J Thromb Thrombolysis. 2005. PMID: 16261287 Clinical Trial.
A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK, Weissman NJ, Picard MH, Zile MR, Pettigrew V, Shen S, Tatsuno J, Hibberd MG, Tzivoni D, Wackers FJ; EVOLVE Investigators. Jang IK, et al. Among authors: wackers fj. Am Heart J. 2008 Jan;155(1):113.e1-8. doi: 10.1016/j.ahj.2007.08.020. Epub 2007 Nov 1. Am Heart J. 2008. PMID: 18082500 Clinical Trial.
Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction.
Chia S, Nagurney JT, Brown DF, Raffel OC, Bamberg F, Senatore F, Wackers FJ, Jang IK. Chia S, et al. Among authors: wackers fj. Am J Cardiol. 2009 Feb 1;103(3):333-7. doi: 10.1016/j.amjcard.2008.09.085. Epub 2008 Nov 17. Am J Cardiol. 2009. PMID: 19166685 Clinical Trial.
Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging.
Udelson JE, Heller GV, Wackers FJ, Chai A, Hinchman D, Coleman PS, Dilsizian V, DiCarli M, Hachamovitch R, Johnson JR, Barrett RJ, Gibbons RJ. Udelson JE, et al. Among authors: wackers fj. Circulation. 2004 Feb 3;109(4):457-64. doi: 10.1161/01.CIR.0000114523.03312.7D. Epub 2004 Jan 20. Circulation. 2004. PMID: 14734517 Clinical Trial.
Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: two Phase 3 international trials in comparison with radionuclide perfusion imaging.
Senior R, Monaghan M, Main ML, Zamorano JL, Tiemann K, Agati L, Weissman NJ, Klein AL, Marwick TH, Ahmad M, DeMaria AN, Zabalgoitia M, Becher H, Kaul S, Udelson JE, Wackers FJ, Walovitch RC, Picard MH; RAMP-1 and RAMP-2 Investigators. Senior R, et al. Among authors: wackers fj. Eur J Echocardiogr. 2009 Jan;10(1):26-35. doi: 10.1093/ejechocard/jen321. Eur J Echocardiogr. 2009. PMID: 19131498 Clinical Trial.
251 results